CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials

Even though chemotherapy and immunotherapy emerged to limit continual and unregulated proliferation of cancer cells, currently available therapeutic agents are associated with high toxicity levels and low success rates. Additionally, ongoing multi-targeted therapies are limited only for few carcinog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genes (Basel)
Hauptverfasser: Khalaf, Khalil, Janowicz, Krzysztof, Dyszkiewicz-Konwińska, Marta, Hutchings, Greg, Dompe, Claudia, Moncrieff, Lisa, Jankowski, Maurycy, Machnik, Marta, Oleksiewicz, Urszula, Kocherova, Ievgeniia, Petitte, Jim, Mozdziak, Paul, Shibli, Jamil A., Iżycki, Dariusz, Józkowiak, Małgorzata, Piotrowska-Kempisty, Hanna, Skowroński, Mariusz T., Antosik, Paweł, Kempisty, Bartosz
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7463827/
https://ncbi.nlm.nih.gov/pubmed/32796761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes11080921
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge